Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Gene

Search results

No.

KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related

Cholesterol metabolism 💬

[1] ANGPTL3 💬

Evinacumab 💬

Evinacumab

[1] 79 💬

Cholesterol metabolism 💬

[1] APOB 💬

Mipomersen sodium 💬

Mipomersen

[1] 79 💬

Cholesterol metabolism 💬

[1] APOC3 💬

Volanesorsen 💬

Volanesorsen

[1] 265 💬

Cholesterol metabolism 💬

[1] APOC3 💬

Volanesorsen sodium 💬

Volanesorsen

[1] 265 💬

Cholesterol metabolism 💬

[1] CETP 💬

Anacetrapib 💬

Anacetrapib

[1] 79 💬

Cholesterol metabolism 💬

[1] CETP 💬

Torcetrapib 💬

Torcetrapib

[1] 79 💬

Cholesterol metabolism 💬

[1] LIPA 💬

Sebelipase alfa 💬

Sebelipase alfa

[1] 19 💬

Disease ID

Name

Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis;

Cholesterol metabolism 💬

[2] LIPC, LPL 💬

Dextran sulfate sodium 💬

Dextran

[3] 2 , 79, 97 💬

Cholesterol metabolism 💬

[1] PCSK9 💬

Alirocumab 💬

Alirocumab

[1] 79 💬

Cholesterol metabolism 💬

[1] PCSK9 💬

Evolocumab 💬

Evolocumab

[2] 79, 222 💬

Disease ID	Name
79	Homozygous familial hypercholesterolemia;Familial hypercholesterolaemia;
222	Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN;